Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: SMN2
Name: survival of motor neuron 2 centromeric
Location: 05q13.2
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT00485511 A Trial of Hydroxyurea in Spinal Muscular Atrophy View
NCT03837184 Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies View
NCT01671384 Valproate and Levocarnitine in Children With Spinal Muscular Atrophy View
NCT02550691 Identification of a Biomarker Associated With Cis-duplication of the SMN1 Gene View
NCT01059240 SMN Copy Number Distribution in Mali West Africa View
NCT05760209 SMN Circular RNAs as Potential New Targets and Biomarkers for SMA View
NCT05544994 The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy View
NCT00155168 Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System View
NCT03381729 Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy View
NCT03461289 Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 View
NCT05769465 MAP THE SMA a Machine-learning Based Algorithm to Predict THErapeutic Response in Spinal Muscular Atrophy View
NCT03306277 Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 View
NCT03505099 Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy SMA for Patients With Multiple Copies of SMN2 View
NCT05335876 Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials View
NCT03955679 AveXis Managed Access Program Cohort for Access to AVXS-101 View
NCT04317196 Association of Copy Number Variations in the SMN Genes With Acute Kidney Injury After Heart Surgery View
NCT05861999 A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy View
NCT05861986 A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy View
NCT02876094 Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy View